benefits of compounded tirzepatide vs. Zepbound – Forbes Health Tirzepatide $125/mo Compounded (vs $1,069

Retatrutide vs Tirzepatide Retatrutide, a first-in-class triple hormone receptor agonist targeting GLP-1, GIP, and glucagon receptors, demonstrates unprecedented weight loss efficacy in clinical trialsup to 24.2% body weight reduction at 48 weeks

Tesamorelin: pituitary first Tesamorelin is a synthetic analog of growth hormone releasing hormone (GHRH) consisting of the full 44-amino-acid sequence of endogenous GHRH with a trans-2-hexenoic acid group added to the N-terminus for stability

Endotext [StatPearls]

Over 61% of healthcare providers prefer GLP-1 drugs due to cardiovascular risk reduction benefits, impacting nearly 32% of high-risk patients globally